- The World Health Organization and Vechain cooperate against a global mafia that spends over 100,000 people per year with its fake medication.
- With its supply chain monitoring technology, Vechain pursues and verified the original origin of medication in real time.
According to the World Health Organization, more than 100,000 people die from fake medication every year. The deaths are not due to a lack of medication, but to compositions that differ from the original, which can lead to fatal doses and unpredictable fatal side effects.
The proof of medication rightness through Vechain can counteract this. Now there is a collaboration with the WHO to examine the origin of vaccines and other medicines in real time.
The crisis is in the supply chain
Vaccines, antibiotics and medical emergency equipment reach patients worldwide, but in the supply chain there has been no evidence of authenticity. The WHO can distribute medication, but not check every dose in real time.
According to the WHO, one of ten medication in countries with low incomes is fake or inferior. This leads to over 100,000 deaths and billions in losses due to callbacks, fraud and abuse annually.
Vechain offers a solution by providing a falsification -safe, transparent supply chain level. It enables QR-linked product identities, unchangeable delivery check and cold chain integrity assessment. These tools are already in use and provide evidence where there was none.
The VECHAIN blockchain test procedure
The blockchain system from Vechain corresponds The GDPR and GXP standards and supports a scalable, modular public-private hybrid use.
VECHAIN X WHO
They Died from Fake Medicine.
Not a Lack of Supply — a Lack of Proof.100,000+ people die every year from counterfeit drugs.
Not because help didn’t exist.
But because there was no trust in the supply chain
The World Health Organization can distribute… pic.twitter.com/TzmXffAvua— Sebastian.vet Ⓥ
(@PERE_Mainz) May 26, 2025
VECHAIN-REFERENTANT SEBASTIAN.VET emphasizedThe fact that Veakain adds the role of the WHO by providing verifiable evidence not medicine itself. Together they create global trust in the supply chain.
The Vechain technology does even more
In addition to the healthcare system, VECHAIN develops a behavior index to support environmental, social and governance initiatives (ESG). This index records the real human behavior that affects communities and takes into account the growing demands on sustainability and regulation.
In China, Vechain is already dealing with an urgent vaccine scandal, in which hundreds of thousands of faulty doses came into the prescribed vaccination programs. The Chinese government revoked licenses and called back uncertain vaccines, which reveals systemic problems in the production and distribution.
In cooperation with the certification company DNV GL, VECHAIN IoT devices use data on production, transport temperatures and the distribution of vaccines. This data is stored unchangeable in the VECHAINTHOR blockchain, so that every vaccine dose has a clear ID to which consumers and supervisory authorities can access.
New applications and the future
Sebastian emphasizes that blockchain has to go beyond meme coins and speculations. In his opinion, Vechain is best positioned to lead the change towards verifiable trust in supply chains and ESG efforts.
In a recently published update, we reported on the introduction of a crosschain bridge by Vechain, which improves interoperability with other blockchains. This upgrade facilitates the smooth transfer of assets and strengthens Vechain’s position in corporate and supply chains applications.
Analysts assume that the Crosschain-Bridge will increase the course of Vechain by 2025 by 150 to 200 percent. The technical range of the platform also strengthens its position in the decentralized finance and in the multicia system.
The current course from Vechain is $ 0.0278, with a daily turnover of over 43 million dolar.
In addition, Bayer China is used to protect data to protect data from clinical studies. This goes far beyond pure supply chain logistics.
No Comments